Longevity-linked APOE2 gene variant helps neurons repair DNA and resist aging
Peer-Reviewed Publication
Updates every hour. Last Updated: 23-May-2026 05:16 ET (23-May-2026 09:16 GMT/UTC)
People who carry the APOE2 version of the apolipoprotein E gene are more likely to live to advanced age and are partly protected against Alzheimer's disease, but scientists have struggled to explain why. A new study from the Buck Institute for Research on Aging, now published in Aging Cell, offers a mechanistic answer: APOE2 helps human neurons keep their DNA intact and resist becoming senescent, a damaged, dysfunctional state that accumulates with age and contributes to neurodegeneration.
A new study led by researchers at Trinity College Dublin in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, estimates the value-based prices of these medicines across 174 countries. The study shows that while disease-modifying therapies (DMTs) may offer substantially greater health benefits than usual care, their real-world impact will depend on whether they are priced in ways that health systems can afford.
A new review published in Reviews on Recent Clinical Trials explores this rapidly emerging possibility. Authored by researchers from Parc Taulí Hospital Universitari and the Universitat Autònoma de Barcelona, the paper examines the promise — and the limits — of Virtual Clinical Trials (VCTs): computer-based simulations that model how drugs and treatments might behave in the human body.
Carbapenem-resistant Enterobacterales are critical priority pathogens posing a high risk for public health and patient safety, as they cause difficult-to-treat infections with limited available treatment options and an insufficient development pipeline for new antibiotics.
The American Society for Nutrition Foundation (ASN Foundation) and the Novo Nordisk Foundation today announced the latest recipients of the annual ASN Foundation-Novo Nordisk Foundation Henrik Dam and Flemming Quaade Awards, now in their second year. The awards recognize two scientists whose work is driving new insights and solutions in nutrition and obesity.
A Chinese Medical Journal study reveals Rhein, a rhubarb-derived compound, protects against severe acute pancreatitis-associated intestinal injury by activating peroxisome proliferator-activated receptor γ (PPARγ) to suppress NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome and reprogram macrophage polarization from pro-inflammatory M1 to anti-inflammatory M2 phenotype. Rhein restored intestinal barrier integrity and reduced endotoxemia—effects abolished by PPARγ inhibition. This identifies the PPARγ/NLRP3/macrophage axis as a promising therapeutic target for SAP complications.
A new study shows that a simple measurement from routine chest X-rays can help predict survival among patients with lung cancer and breathing disorders. Researchers found that lower diaphragmatic dome height (DDH) before surgery was associated with poorer long-term outcomes and higher respiratory-related deaths. This is the first study to establish DDH as a practical prognostic marker, offering a low-cost, widely accessible way to identify high-risk patients and guide treatment decisions.